Rizwana Chaudhri
National Coordinating Investigator, Shifa Tameer-e-Millat University, Pakistan
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rizwana Chaudhri as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:26 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03475342 · World Maternal Antifibrinolytic Trial_2London School of Hygiene and Tropical Medicine · completed · Intrapartum - Moderate and Severe Anaemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:26 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Risk factors for peripartum hysterectomy among women with postpartum haemorrhage: analysis of data from the WOMAN trial.BMC Pregnancy Childbirth · 201859 citationsRCR 4.4
- Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.Crit Care · 202028 citationsRCR 2.1
- Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.Health Technol Assess · 202128 citationsRCR 2.3
- Prevalence and presentation of chronic venous disease in Pakistan: a multicentre study.Phlebology · 201327 citationsRCR 1.4
- The WOMAN trial: clinical and contextual factors surrounding the deaths of 483 women following post-partum haemorrhage in developing countries.BMC Pregnancy Childbirth · 202025 citationsRCR 2.0
- Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach.BMJ Glob Health · 202020 citationsRCR 1.3
- 17 citationsRCR 2.4
- Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trials.PLoS One · 202016 citationsRCR 1.3
- Secondary analysis of the WOMAN trial to explore the risk of sepsis after invasive treatments for postpartum hemorrhage.Int J Gynaecol Obstet · 201911 citationsRCR 0.6
- The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial.BMC Pregnancy Childbirth · 201810 citationsRCR 0.6